Coffee polyphenol consumption improves postprandial hyperglycemia associated with impaired vascular endothelial function in healthy male adults

Nutrition Research

Volumn 35, Issue 10, 2015, Pages 873-881

  Jokura, Hiroko ^a   Watanabe, Isamu ^a   Umeda, Mika ^a   Hase, Tadashi ^a   Shimotoyodome, Akira ^a  

^a KAO CORPORATION   (Japan)

Author keywords

Blood glucose; Coffee polyphenol; Flow mediated dilatation; GLP 1; Insulin

Indexed keywords

BIOLOGICAL MARKER; COFFEE POLYPHENOL EXTRACT; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; PLACEBO; PLANT EXTRACT;

ADULT; ARTICLE; BODY MASS; COFFEE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; MALE; NORMAL HUMAN; OXIDATIVE STRESS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VASCULAR ENDOTHELIUM; ANALYSIS; BLOOD; CHEMISTRY; COFFEA; DRUG EFFECTS; HEAT; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; PLANT SEED;

ADULT; BLOOD GLUCOSE; COFFEA; ENDOTHELIUM, VASCULAR; GLUCAGON-LIKE PEPTIDE 1; HOT TEMPERATURE; HUMANS; HYPERGLYCEMIA; JAPAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PLACEBOS; PLANT EXTRACTS; POLYPHENOLS; SEEDS; SINGLE-BLIND METHOD;

EID: 84941805052     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.07.005     Document Type: Article

References (38)

1. Takami H., Nakamoto M., Uemura H., Katsuura S., Yamaguchi M., Hiyoshi M., et al. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol 2013, 23:12-20.
2. Grosso G., Marventano S., Galvano F., Pajak A., Mistretta A. Factors associated with metabolic syndrome in a Mediterranean population: role of caffeinated beverages. J Epidemiol 2014, 24:327-333.
3. Grosso G., Stepaniak U., Micek A., Topor-Mądry R., Pikhart H., Szafraniec K., et al. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr 2014, [Epub ahead of print]. 10.1007/s00394-014-0789-6.
4. Van Dam R.M., Hu F.B. Coffee consumption and risk of type 2 diabetes. J Am Med Assoc 2005, 294:97-104.
5. Sugiyama K., Kuriyama S., Akhter M., Kakizaki M., Nakaya N., Ohmori-Matsuda K., et al. Coffee consumption and mortality due to all causes, cardiovascular diseases, and cancer in Japanese women. J Nutr 2010, 140:1007-1013.
6. Van Dam R.M., Willett W.C., Manson J.E., Hu F.B. Coffee caffeine and risk of type 2 diabetes: A prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 2006, 29:398-403.
7. Godos J., Pluchinotta F.R., Marventano S., Buscemi S., Li Volti G., Galvano F., et al. Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr 2014, 65:925-936.
8. Fukushima Y., Ohie T., Yonekawa Y., Ohie T., Yonekawa Y., Yonemoto K., et al. Coffee and green tea as a large source of antioxidant polyphenols in the Japanese population. J Agric Food Chem 2009, 57:1253-1259.
9. Fraga C.G., Galleano M., Verstraeten S.V., Oteiza P.I. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Aspects Med 2010, 31:435-445.
10. Clifford M.N. Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J Sci Food Agric 1999, 79:362-372.
11. Murase T., Misawa K., Minegishi Y., Minegishi Y., Aoki M., Ominami H., et al. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab 2011, 300:E122-E133.
12. Ota N., Soga S., Murase T., Shimotoyodome A., Hase T. Consumption of coffee polyphenols increases fat utilization in humans. J Health Sci 2010, 56:745-751.
13. Soga S., Ota N., Shimotoyodome A. Stimulation of postprandial fat utilization in healthy humans by daily consumption of chlorogenic acids. Biosci Biotechnol Biochem 2013, 77:1633-1636.
14. Fujii Y., Osaki N., Hase T., Shimotoyodome A. Ingestion of coffee polyphenols increases postprandial release of the active GLP-1(7-36) amide in C57BL/6J mice. J Nutr Sci 2015, 4:1-9.
15. Samocha-Bonet D., Wong O., Synnott E.L., Piyaratna N., Douglas A., Gribble F.M., et al. Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. J Nutr 2011, 141:1233-1238.
16. Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
17. Nystrom T., Gutniak M.K., Zhang Q., Fan Z., Jens J.H., Bo A. Effect of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol 2004, 287:E1209-E1215.
18. Liu H., Dear A.E., Knudsen L.B., Simpson R.W. A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules. J Endocrinol 2009, 201:59-66.
19. Avogaro A., Albiero M., Menegazzo L., Kreutzenberg S., Fadini G.P. Endothelial dysfunction in diabetes. Diabetes Care 2010, 33:1607-1609.
20. Kubota T., Kubota N., Kumagai H., Yamaguchi S., Kozono H., Takahashi T., et al. Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab 2011, 13:294-307.
21. Ochiai R., Jokura H., Suzuki A., Tokimitsu I., Ohishi M., Komai N., et al. Green coffee bean extract improves human vasoreactivity. Hypertens Res 2004, 27:731-737.
22. Kawano H., Motoyama T., Hirashima O., Hirai N., Miyao Y., Sakamoto T., et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999, 34:146-154.
23. Lawrence M., Peter M., Cummings B.A., Karen G., Bassam A., Nassar M.B. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. JACC 2000, 36:2185-2191.
24. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat?. Diabetes 2005, 54:1-7.
25. Singh B., Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes 2010, 1:36-47.
26. Buscemi S., Batsis J.A., Arcoleo G., Verga S. Coffee and endothelial function: a battle between caffeine and antioxidants. Eur J Clin Nutr 2010, 64:1242-1243.
27. Shechter M., Shalmon G., Scheinowitz M., Koren-Moraq N., Feinberg M.S., Harats D., et al. Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease. Am J Cardiol 2011, 107:1255-1261.
28. Cheraskin E., Ringsdorf W.M., Setyaadmadja A.T., Barrett R.A. Effect of caffeine versus placebo supplementation on blood-glucose concentration. Lancet 1967, 1:1299-1300.
29. Whitehead N., White H. Systematic review of randomised controlled trials of the effects of caffeine or caffeinated drinks on blood glucose concentrations and insulin sensitivity in people with diabetes mellitus. J Hum Nutr Diet 2013, 26:111-125.
30. Johnston K.L., Clifford M.N., Morgan L.M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: Glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003, 78:728-733.
31. Ochiai R., Sugiura Y., Shioya Y., Otsuka K., Katsuragi Y., Hashiguchi T. Coffee polyphenols improve peripheral endothelial function after glucose loading in healthy male adults. Nutr Res 2014, 34:155-159.
32. Carrel G., Egli L., Tran C., Schneiter P., Giusti V., D'Alessio D., et al. Contributions of fat and protein to the incretin effect of a mixed meal. Am J Clin Nutr 2011, 94:997-1003.
33. Karamanlis A., Chaikomin R., Doran S., Bellon M., Bartholomeusz F.D., Wishart J.M. Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects. Am J Clin Nutr 2007, 86:1364-1368.
34. Paravicini T.M., Touyz R.M. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008, 31:S170-S180.
35. Nikolaidis L.A., Elahi D., Hentosz T., Doverspike A., Huerbin R., Zourelias L., et al. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation 2004, 110:955-961.
36. Nikolaidis L.A., Elahi D., Shen Y.T., Shannon R.P. Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2005, 289:H2401-H2408.
37. Johnson K.M.S., Edgerton D.S., Rodewald T., Scott M., Farmer B., Neal D. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels. Am J Physiol Endocrinol Metab 2007, 293:E1085-E1091.
38. Chai W., Dong Z., Wang N., Wang W., Tao L., Cao W., et al. Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism. Diabetes 2012, 61:888-896.